We are live on ! Find out more
FWP

Forward Pharma A/S American Depositary Shares
FWP

Delisted

FWP was delisted on the 27th of December, 2022.

Back to rankings

5 hedge funds and large institutions have $6.72M invested in Forward Pharma A/S American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

2% more capital invested

Capital invested by funds: $6.61M → $6.72M (+$113K)

38% less funds holding

Funds holding: 8 → 5 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
5
Holders Change
-3
Holders Change %
-37.5%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$82.5K
2
Morgan Stanley
Morgan Stanley
New York
+$15.6K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$881K
2
Renaissance Technologies
Renaissance Technologies
New York
-$436K
3
Citadel Advisors
Citadel Advisors
Florida
-$93K
4
UBS Group
UBS Group
Switzerland
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$4.54M -$881K -118,785 -18%
Morgan Stanley
2
Morgan Stanley
New York
$1.56M +$15.6K +2,099 +1%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$495K +$82.5K +11,125 +24%
OIA
4
OneDigital Investment Advisors
Kansas
$121K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
– -$436K -63,700 Closed
Citadel Advisors
6
Citadel Advisors
Florida
– -$93K -13,514 Closed
UBS Group
7
UBS Group
Switzerland
– -$4K -599 Closed

FWP Hedge Fund Activity: Q2 2021 in Review

5 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q2 2021, worth a combined $6.72M — up 1.7% from $6.61M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of FWP and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Acadian Asset Management, adding an estimated $82.5K. The largest seller was BVF Inc, cutting an estimated $881K.

  • 5 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q2 2021, down from 8 in Q1 2021.
  • Funds reported $6.72M of Forward Pharma A/S American Depositary Shares stock for Q2 2021, up 1.7% quarter-over-quarter.
  • 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q2 2021 and 3 closed out, a net change of -3 holders.
  • The largest Forward Pharma A/S American Depositary Shares buyer in Q2 2021 was Acadian Asset Management, an estimated $82.5K added.
  • The largest Forward Pharma A/S American Depositary Shares seller in Q2 2021 was BVF Inc, an estimated $881K sold.

Based on aggregated 13F filings for Q2 2021.